As of November 7, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Modular Medical, Inc. The largest reported stake is Solas Capital Management, LLC's, at 9.9%. 16 filings are on record since July 2, 2025 (Schedule 13G/A, August 14, 2026).
Sell to companies like Modular Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Pathfinder Asset Management Ltd · Sole voting: 399,775 · Shared voting: 0 · Sole dispositive: 399,775 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-11-06
- · Holder: Pathfinder Asset Management Ltd · Percent: 4.2% · SCHEDULE 13G
- · Reporting person: Solas Capital Management, LLC · Sole voting: 0 · Shared voting: 552,171 · Sole dispositive: 0 · Shared dispositive: 552,171 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Bleichroeder LP · Sole voting: 336,986 · Shared voting: 0 · Sole dispositive: 336,986 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-13
- · Holder: Pathfinder Asset Management Ltd · Percent: 7.4% · SCHEDULE 13G
Modular Medical, Inc. has 16 Schedule 13D or 13G filings on record since 2025-07-02. 3 holders' latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Solas Capital Management, LLC | 9.9% | 552,171 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| AWM Investment Company, Inc. | 9.9% | 540,576 | SCHEDULE 13G, 2026-05-04 | 2026-03-31 |
| Bleichroeder LP | 6.23% | 336,986 | SCHEDULE 13G, 2026-08-13 | 2026-06-30 |
| 683 Capital Management, LLC | 4.67% | 259,240 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Pathfinder Asset Management Ltd | 4.2% | 399,775 | SCHEDULE 13G/A, 2026-11-06 | 2026-09-10 |
| Alyeska Investment Group, L.P. | 3.81% | 1,041,666 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| Bard Associates, Inc. | 0.1% | 102,831 | SCHEDULE 13G/A, 2026-05-13 | 2026-05-13 |
Holding shares or following this stake? See who's behind Modular Medical, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Modular Medical, Inc. and the records around it.
Modular Medical, Inc. elsewhere on the record
- Leadership changes Sep 2026
- Form D filing Apr 2025
- Who owns it
Companies that share a holder
- Solas Capital Management, LLC also filed stake reports on 5 other companies: FENNEC PHARMACEUTICALS INC. (Aug 2026), MAIA Biotechnology, Inc. (Aug 2026), SANUWAVE Health, Inc. (Aug 2026)
- 683 Capital Management, LLC also filed stake reports on 10 other companies: Perceptive Capital Solutions Corp (Aug 2026), Gossamer Bio, Inc. (Jun 2026), FRACTYL HEALTH, INC. (May 2026)
- BARD ASSOCIATES INC also filed stake reports on 10 other companies: Elauwit Connection, Inc (May 2026), Mobilicom Ltd (May 2026), Bridgeline Digital, Inc. (Feb 2026)
Watch Modular Medical, Inc.
Get an email when Modular Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Modular Medical, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Modular Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Modular Medical, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Solas Capital Management, LLC | 0 | 552,171 | 0 | 552,171 | SCHEDULE 13G/A, 2026-08-14 |
| Frederick Tucker Golden | 0 | 552,171 | 0 | 552,171 | SCHEDULE 13G/A, 2026-08-14 |
| Bleichroeder LP | 336,986 | 0 | 336,986 | 0 | SCHEDULE 13G, 2026-08-13 |
| Bleichroeder Holdings LLC | 336,986 | 0 | 336,986 | 0 | SCHEDULE 13G, 2026-08-13 |
| Andrew Gundlach | 336,986 | 0 | 336,986 | 0 | SCHEDULE 13G, 2026-08-13 |
| Pathfinder Asset Management Ltd | 399,775 | 0 | 399,775 | 0 | SCHEDULE 13G/A, 2026-11-06 |
The latest filing identifies Modular Medical, Inc. by CUSIP 60785L207 and gives its principal executive office as 10740 THORNMINT ROAD, SAN DIEGO, CA 92127 (SCHEDULE 13G/A, 2026-11-06).
What the percentages are based on
All such shares of Common Stock in the aggregate represent beneficial ownership of approximately 9.99% of the Common Stock based on (i) 5,413,160 shares of Common Stock outstanding as of June 22, 2026 as represented by the Issuer in its 10K filed with the Securities and Exchange Commission on June 29, 2026, plus (ii) 114,076 shares of Common Stock issuable upon the exercise of the Warrants.Solas Capital Management, LLC, SCHEDULE 13G/A, 2026-08-14
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-02 | Bard Associates Inc | 5.6% | SCHEDULE 13G |
| 2025-08-14 | Alyeska Investment Group, L.P. | 3.81% | SCHEDULE 13G/A |
| 2025-11-14 | 683 Capital Management, LLC | 3.3% | SCHEDULE 13G/A |
| 2025-11-14 | Solas Capital Management, LLC | 7.7% | SCHEDULE 13G/A |
| 2026-02-17 | Solas Capital Management, LLC | 6.8% | SCHEDULE 13G/A |
| 2026-03-10 | 683 Capital Management, LLC | 5.52% | SCHEDULE 13G |
| 2026-03-23 | Pathfinder Asset Management Ltd | 6.4% | SCHEDULE 13G |
| 2026-05-04 | AWM Investment Company, Inc. | 9.9% | SCHEDULE 13G |
| 2026-05-13 | Bard Associates, Inc. | 0.1% | SCHEDULE 13G/A |
| 2026-05-15 | 683 Capital Management, LLC | 4.67% | SCHEDULE 13G/A |
| 2026-05-15 | Solas Capital Management, LLC | 9.6% | SCHEDULE 13G/A |
| 2026-08-07 | Pathfinder Asset Management Ltd | 7.4% | SCHEDULE 13G |
| 2026-08-13 | Bleichroeder LP | 6.23% | SCHEDULE 13G |
| 2026-08-14 | Solas Capital Management, LLC | 9.9% | SCHEDULE 13G/A |
| 2026-11-05 | Pathfinder Asset Management Ltd | 4.2% | SCHEDULE 13G |
| 2026-11-06 | Pathfinder Asset Management Ltd | 4.2% | SCHEDULE 13G/A |
Questions about who owns Modular Medical, Inc.
Who owns Modular Medical, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Modular Medical, Inc.: Solas Capital Management, LLC (9.9%, Schedule 13G/A, filed 2026-08-14), AWM Investment Company, Inc. (9.9%, Schedule 13G, filed 2026-05-04) and Bleichroeder LP (6.23%, Schedule 13G, filed 2026-08-13).
Who are the largest shareholders of Modular Medical, Inc.?
By the share each holder's latest filing reports, the largest holders of Modular Medical, Inc. on this page are Solas Capital Management, LLC (9.9%), AWM Investment Company, Inc. (9.9%) and Bleichroeder LP (6.23%).
When did Solas Capital Management, LLC buy into Modular Medical, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Solas Capital Management, LLC on this page is the Schedule 13G/A, filed 2025-11-14, reporting 7.7%; its latest, Schedule 13G/A filed 2026-08-14, reports 9.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 16 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Modular Medical, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 28, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| September 29, 2026 | Leadership change: Jeffrey Goldberg departs, Director, and 1 more | — | Leadership changes | Source |
| April 7, 2025 | Form D, private offering | $12M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for Modular Medical, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.